Health ❯ Pharmaceuticals

Weight Management

Obesity Treatment GLP-1 Agonists Medications GLP-1 Drugs Obesity Injectable Drugs Obesity Treatments GLP-1 Medications Diabetes Treatment Clinical Research Access to Medication Ozempic Wegovy Injectable Treatments Drug Safety GLP-1 Treatments Drug Approval GLP-1 Zepbound GLP-1 Receptor Agonists Weight Loss

Eli Lilly Tightens GLP-1 Grip, Guides Up to $83 Billion for 2026

The outlook reflects heavy reliance on two GLP-1 brands despite growing oral competition.

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

FDA Clears Wegovy Pill, Handing Novo Nordisk a Short-Term Edge in Obesity-Drug Race

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro